Works matching AU Xu, Chuanrui
Results: 13
Enhanced anti-tumor effect of liposomal Fasudil on hepatocellular carcinoma in vitro and in vivo.
- Published in:
- PLoS ONE, 2019, v. 14, n. 10, p. 1, doi. 10.1371/journal.pone.0223232
- By:
- Publication type:
- Article
Nitric oxide-releasing micelles with intelligent targeting for enhanced anti-tumor effect of cisplatin in hypoxia.
- Published in:
- Journal of Nanobiotechnology, 2021, v. 19, n. 1, p. 1, doi. 10.1186/s12951-021-00989-z
- By:
- Publication type:
- Article
Glioma Shapes Blood–Brain Barrier Integrity and Remodels the Tumor Microenvironment: Links with Clinical Features and Prognosis.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 19, p. 5863, doi. 10.3390/jcm11195863
- By:
- Publication type:
- Article
Integrating bulk and single-cell RNA sequencing reveals cellular heterogeneity and immune infiltration in hepatocellular carcinoma.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 11, p. 2195, doi. 10.1002/1878-0261.13190
- By:
- Publication type:
- Article
Co-delivery of Bmi1 small interfering RNA with ursolic acid by folate receptor-targeted cationic liposomes enhances anti-tumor activity of ursolic acid in vitro and in vivo.
- Published in:
- Drug Delivery, 2019, v. 26, n. 1, p. 794, doi. 10.1080/10717544.2019.1645244
- By:
- Publication type:
- Article
Validation of Bmi1 as a Therapeutic Target of Hepatocellular Carcinoma in Mice.
- Published in:
- International Journal of Molecular Sciences, 2014, v. 15, n. 11, p. 20004, doi. 10.3390/ijms151120004
- By:
- Publication type:
- Article
Increased ceramide production sensitizes breast cancer cell response to chemotherapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Integrating cell interaction with transcription factors to obtain a robust gene panel for prognostic prediction and therapies in cholangiocarcinoma.
- Published in:
- Frontiers in Genetics, 2022, v. 13, p. 1, doi. 10.3389/fgene.2022.981145
- By:
- Publication type:
- Article
Delivery Of miR-375 And Doxorubicin By Lipid-Coated Hollow Mesoporous Silica Nanoparticles To Overcome Multiple Drug Resistance In Hepatocellular Carcinoma [Corrigendum].
- Published in:
- International Journal of Nanomedicine, 2019, v. 14, p. 8753, doi. 10.2147/IJN.S234860
- By:
- Publication type:
- Article
Delivery of miR-375 and doxorubicin hydrochloride by lipid-coated hollow mesoporous silica nanoparticles to overcome multiple drug resistance in hepatocellular carcinoma.
- Published in:
- International Journal of Nanomedicine, 2017, v. 12, p. 5271, doi. 10.2147/IJN.S135306
- By:
- Publication type:
- Article
Antitumor activity of a folate receptor-targeted immunoglobulin G-doxorubicin conjugate.
- Published in:
- International Journal of Nanomedicine, 2017, v. 12, p. 2505, doi. 10.2147/IJN.S125591
- By:
- Publication type:
- Article
A novel hydrolysis-resistant lipophilic folate derivative enables stable delivery of targeted liposomes in vivo.
- Published in:
- International Journal of Nanomedicine, 2014, v. 9, p. 4581, doi. 10.2147/IJN.S69115
- By:
- Publication type:
- Article
Bmi1 Is Required for Hepatic Progenitor Cell Expansion and Liver Tumor Development.
- Published in:
- PLoS ONE, 2012, v. 7, n. 9, p. 1, doi. 10.1371/journal.pone.0046472
- By:
- Publication type:
- Article